This filing is a routine proxy statement with no new operational or financial disclosures. Monitor the upcoming annual meeting for any unexpected developments, but no immediate trading action is warranted.
CGEN drugs
CGEN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 3 $2.38entry
- T+1 · 4mo ago 0.00%α −1.80% · $2.38
- T+5 · 3mo ago −1.68%α −3.71% · $2.34
- T+20 · 3mo ago +7.56%α +6.33% · $2.56
- T+60 · 21d ago −18.70%α −20.48% · $1.94
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Compugen Ltd. filed its proxy statement for the 2026 Annual General Meeting via Form 6-K. The meeting will cover the election of eight directors, approval of an amended compensation policy, and re-appointment of the auditor. This is a routine governance filing with no material financial data or operational updates, and the stock impact is expected to be neutral.
Key Facts
- The 2026 Annual General Meeting is scheduled for September 10, 2026.
- Shareholders will vote on the election of eight directors, including one new nominee (Dr. Michele Holcomb).
- Shareholders will vote on an amended compensation policy, which formalizes a minimum one-year cliff vesting for equity awards.
- Kost Forer Gabbay & Kasierer (EY Global) is proposed for re-appointment as independent auditor for FY2026.
- The record date for voting is July 27, 2026.
- As of July 30, 2026, the company had 94,727,926 ordinary shares outstanding.
- All office holders as a group beneficially own 3.30% of outstanding shares.
- Audit fees for FY2025 were $217,000, down from $222,000 in FY2024.
Financial Impact
No material financial impact. Routine governance and compensation policy updates.
Risk Factors
- No material risks identified from this routine governance filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-003756 |
| Document: zk2635809.htm | 0001178913-26-003756 |
| Document: 0001178913-26-003756-index-headers.html | 0001178913-26-003756 |
| Document: 0001178913-26-003756-index.html | 0001178913-26-003756 |
| Document: 0001178913-26-003756.txt | 0001178913-26-003756 |
Track record
9 reports on CGEN
Filters
- Nov 9, 20267d ago 6-K Neutral 4/10 Entry $2.14 Now $2.04 −4.67% settles Dec 8
- Aug 3, 202615w ago 6-K Neutral 2/10 Viewing Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Aug 3, 202615w ago 6-K Neutral 4/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Jun 9, 202623w ago EFFECT Neutral 3/10 Entry $2.02 to $2.39 Now $2.04 +0.99% ▲ +18.32% +16.87% vs SPY
- May 18, 202626w ago 6-K Neutral 4/10 Entry $2.86 to $2.03 Now $2.04 −28.67% ▼ −29.02% −30.60% vs SPY
- Apr 24, 202629w ago Insider Cluster Neutral 2/10 Entry $3.10 to $2.61 Now $2.04 −34.19% ▼ −15.81% −19.83% vs SPY
- Apr 14, 202631w ago Insider Cluster Neutral 2/10 Entry $2.88 to $2.87 Now $2.04 −29.17% ▼ −0.35% −6.64% vs SPY
- Apr 13, 202631w ago 144 Neutral 3/10 Entry $2.76 to $2.87 Now $2.04 −26.09% ▲ +3.99% −3.74% vs SPY
- Mar 26, 202633w ago Insider Cluster Neutral 3/10 Entry $2.06 to $3.10 Now $2.04 −0.97% ▲ +50.49% +39.82% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers